Dalphene Labs · The business of medical aestheticsFor owners, injectors & clinic teamsJoin the brief
Daily edition

Dalphene Labs

Medical aesthetics
Industry

Deals, market moves, supply, and new products and approvals.

22 briefs

Lead · Industry

European Commission approves Boey as the first short duration neurotoxin

Dalphene Labs · Industry · Published Jul 18, 2026

European Commission approves Boey as the first short duration neurotoxin

Allergan's Boey Neurotoxin Wins European Commission Approval

The European Commission approved Boey (trenibotulinumtoxinE) on July 17, 2026, for the temporary improvement of moderate to severe glabellar lines in adults, introducing a completely new clinical timeline to the aesthetic market. Developed by Allergan Aesthetics, Boey is the first approved botulinum neurotoxin serotype E, a formulation that works faster and wears off much sooner than traditional serotype A products like Botox Cosmetic.

Read the full brief →

More in Industry

FDA clears SKINVIVE for neck lines, a first for HA

Industry

FDA clears SKINVIVE for neck lines, a first for HA

Allergan's microdroplet HA picks up a second indication, this time on-label for the neck.

Read the brief →
FDA approves Obagi saypha ChIQ hyaluronic acid gel for cheek augmentation

Industry

FDA approves Obagi saypha ChIQ hyaluronic acid gel for cheek augmentation

FDA Approves Obagi saypha ChIQ Hyaluronic Acid Gel for Midface Augmentation

Read the brief →
Cynosure Lutronic launches XERF skin tightening platform in Europe and Middle East

Industry

Cynosure Lutronic launches XERF skin tightening platform in Europe and Middle East

Cynosure Lutronic Launches Dual-Frequency XERF Skin-Tightening Platform in Europe and the Middle East

Read the brief →
FDA clears SkinStylus microneedling device for periorbital wrinkles

Industry

FDA clears SkinStylus microneedling device for periorbital wrinkles

FDA Clears SkinStylus Microneedling Device for Periorbital Wrinkles Across All Fitzpatrick Skin Types

Read the brief →
GC Wellbeing showcases Rebornne acellular dermal matrix skin booster in Tokyo

Industry

GC Wellbeing showcases Rebornne acellular dermal matrix skin booster in Tokyo

GC Wellbeing Showcases Human Acellular Dermal Matrix Skin Booster 'Rebornne' at ASLS Tokyo

Read the brief →
Jetema Botulinum Toxin Receives Regulatory Approval in Thailand

Industry

Jetema Botulinum Toxin Receives Regulatory Approval in Thailand

Jetema Obtains Thai FDA Approval for Jetema The Toxin 100U

Read the brief →
Medik8 launches Exo-PDRN serums to boost microneedling results and recovery

Industry

Medik8 launches Exo-PDRN serums to boost microneedling results and recovery

Medik8 Introduces Exo-PDRN Serum to Optimize Professional Microneedling and Post-Procedure Recovery

Read the brief →
DermDox Group acquires Modern Aesthetics Plastic Surgery in Pennsylvania

Industry

DermDox Group acquires Modern Aesthetics Plastic Surgery in Pennsylvania

DermDox Group Expands Mid-Atlantic Footprint with Modern Aesthetics Acquisition

Read the brief →
Cynosure Lutronic showcases XERF skin tightening system at IMCAS Asia

Industry

Cynosure Lutronic showcases XERF skin tightening system at IMCAS Asia

Cynosure Lutronic Launches XERF RF System for Deep Dermal Tightening at IMCAS Asia

Read the brief →
Health Canada clears Boey, the first serotype-E aesthetic neurotoxin

Industry

Health Canada clears Boey, the first serotype-E aesthetic neurotoxin

A short-acting, fast-onset toxin built on a brand new class gets its first green light anywhere.

Read the brief →
Waldencast sells Obagi Medical to Bridgepoint for up to $460M

Industry

Waldencast sells Obagi Medical to Bridgepoint for up to $460M

A practitioner-distributed skincare and filler brand changes private-equity hands as beauty and medical aesthetics keep converging.

Read the brief →
ParagonCare acquires Haju Medical to expand Southeast Asian distribution

Industry

ParagonCare acquires Haju Medical to expand Southeast Asian distribution

ParagonCare Acquires Haju Medical for A$70 Million, Consolidating K-Aesthetics Hub in Southeast Asia

Read the brief →
Medytox wins China approval for Neuramis filler, launching as Filux

Industry

Medytox wins China approval for Neuramis filler, launching as Filux

A Korean HA filler clears the NMPA, one more step in Korean supply pushing into China.

Read the brief →
Medytox unit wins Korean approval for animal-free 200-unit toxin

Industry

Medytox unit wins Korean approval for animal-free 200-unit toxin

A higher-dose, animal-component-free Korean toxin signals where lower-cost supply is heading.

Read the brief →
Japan's aesthetics market: 1.22 million users, only 2% penetration

Industry

Japan's aesthetics market: 1.22 million users, only 2% penetration

631 billion yen, growing, and chains take roughly half of what converts.

Read the brief →
Korea's filler and device exports hit fresh record in May 2026

Industry

Korea's filler and device exports hit fresh record in May 2026

Filler and energy-device shipments surged into the US and Brazil as derm-led medical tourism set its own record.

Read the brief →
FDA approves Obagi saypha ChIQ, its second US filler

Industry

FDA approves Obagi saypha ChIQ, its second US filler

A cheek and midface HA gel builds out Obagi's injectable line, with the ALOHA data hinting at the real play.

Read the brief →
Foreign patients spent $8.3 billion on Korean medical services in 2025

Industry

Foreign patients spent $8.3 billion on Korean medical services in 2025

Dermatology, not surgery, drives a record 2.01 million foreign patients.

Read the brief →